National Energy Services Reunited Corp. (NESR)

CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	78.7	107.96	67.82	78.85	205.77	75.01
Cash & Short-Term Investments	78.7	107.96	67.82	78.85	205.77	75.01
Cash Growth	16.03%	59.18%	-13.99%	-61.68%	174.32%	2.47%
Accounts Receivable	294.88	249	267.27	258.9	238.9	275.29
Other Receivables	42.57	38.48	39.78	38.27	35.25	18.45
Receivables	337.45	287.48	307.04	297.17	274.15	293.75
Inventory	101.42	96.77	98.43	110.52	93.86	94.26
Prepaid Expenses	9.4	10.15	9.24	0.34	6.04	11.48
Other Current Assets	27.88	38.17	59.18	50.94	47.54	40.72
Total Current Assets	554.85	540.52	541.72	537.81	627.37	515.22
Property, Plant & Equipment	450.87	464.19	474.29	491.03	425.51	437.74
Long-Term Investments	-	27.53	22.98	30.29	7.6	-
Goodwill	645.1	645.1	645.1	645.1	645.1	620.92
Other Intangible Assets	61.04	65.7	84.3	102.91	121.62	110.38
Other Long-Term Assets	57.47	30.66	29.35	21.19	4.11	2.8
Total Assets	1,769	1,774	1,798	1,828	1,831	1,687
Accounts Payable	305.93	304.01	345.74	341.94	306.07	144.61
Accrued Expenses	25.2	27.48	14.67	7.6	5.23	85.07
Short-Term Debt	60.35	59.72	48.89	89.89	78.32	42.36
Current Portion of Long-Term Debt	68.02	70.04	77.24	64.95	17.26	47.5
Current Portion of Leases	35.06	10.79	10.81	8.53	4.4	23
Current Income Taxes Payable	8.01	7.73	8.42	7.26	7.18	9.42
Other Current Liabilities	-	23.75	27.67	23.9	13.42	7.4
Total Current Liabilities	502.57	503.51	533.45	544.07	431.87	359.37
Long-Term Debt	238.65	254.39	331.57	391.86	508.76	308.61
Long-Term Leases	20	20.84	29.27	25.24	2.2	5.5
Long-Term Deferred Tax Liabilities	5.75	5.63	-	-	8.89	21.07
Other Long-Term Liabilities	48.58	49.27	53.03	40.42	35	26.57
Total Liabilities	848.84	865.45	976.25	1,026	1,010	742.64
Common Stock	896.15	894.29	883.87	877.3	856.79	826.61
Retained Earnings	24.26	13.87	-62.44	-75.02	-35.83	117.75
Comprehensive Income & Other	0.07	0.07	0.07	0.07	0.07	0.06
Total Common Equity	920.48	908.23	821.49	802.35	821.03	944.43
Minority Interest	-	-	-	-	-	-0.01
Shareholders' Equity	920.48	908.23	821.49	802.35	821.03	944.42
Total Liabilities & Equity	1,769	1,774	1,798	1,828	1,831	1,687
Total Debt	422.08	415.77	497.78	580.47	610.94	426.97
Net Cash (Debt)	-343.39	-307.81	-429.96	-501.62	-405.17	-351.96
Net Cash Per Share	-3.57	-3.22	-4.54	-5.40	-4.45	-3.95
Filing Date Shares Outstanding	96.35	96.05	95	95	91.04	87.78
Total Common Shares Outstanding	96.35	96.05	95	94.01	91.04	87.78
Working Capital	52.28	37	8.27	-6.25	195.5	155.85
Book Value Per Share	9.55	9.46	8.65	8.53	9.02	10.76
Tangible Book Value	214.34	197.44	92.1	54.34	54.32	213.13
Tangible Book Value Per Share	2.22	2.06	0.97	0.58	0.60	2.43
Land	11.66	11.66	11.66	11.66	11.66	5.1
Buildings	55.98	55.28	57	52.44	41.78	31.83
Machinery	796.54	774.28	780.7	708.96	596.73	583.85
Construction In Progress	24.97	40.29	14.11	11.32	8.94	10.22

Updated Jun 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q